Skip Menu
Subscribe to the phenom-info email list.

Seminar Archives
SPR-15   WIN-15   AUT-14
SPR-14   WIN-14   AUT-13
SPR-13   WIN-13   AUT-12  

PHEnOM Seminar Series

PHEnOM hosts a weekly seminar series during the academic year. All students, faculty and other researchers interested in this area will be encouraged to attend the seminar series. The 1.5 hour seminar will be held in the Rm H671 at the Health Sciences Building (directions) every Thursday 3 - 4:30pm.
To present at the PHEnOM seminar series, contact Norma Coe at

Winter 2016 Schedule

Muxin Zhai, Department of Economics, University of Washington
The impact of maternal exposure to air pollution on infant health.
Peter Zweifel, University of Zurich, Zurich
Willingness-to-Pay for a New Pharmaceutical: Is It Worth the Money? Whose Money?
Paper Available Here
David Kim, Department of Health Services, University of Washington
New Metrics for Economic Evaluation in the Presence of Heterogeneity: Focusing on evaluating policy alternatives rather than treatment alternatives
Brian Dillon, Evans School of Public Policy and Governance, University of Washington
Long-Term Consequences of Consumption Seasonality
Amy Cizik, PORPP, University of Washington
A Markovian cost Utility Model for Soft Tissue Sarcoma
Carol Levin1 and Suzanne Kerns2, 1Department of Global Health and 2Department of Psychiatry and Behavioral Sciences, University of Washington
Including implementation stages in evaluating the costs of mental health interventions: A case study of scaling up evidence based practices in Washington State
Bianca Frogner, Department of Family Medicine, University of Washington
Does unrestricted direct access to physical therapy impact health spending?
Anirban Basu, PORPP, University of Washington
Estimating Price Elasticities from a Value-based Formulary Implementation
Guido Cataife, IMPAQ International, LLC
How much health does a dollar buy? The effect of health care spending on age-adjusted mortality in the US
Kai Yeung, PROPP, University of Washington
Assessing stakeholder experiences and attitudes regarding cures